ArticleJNCI cancer spectrum2019

Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia.

Lih-Wen Mau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.